Passa al contenuto
Merck
  • Sprouty2 positively regulates T cell function and airway inflammation through regulation of CSK and LCK kinases.

Sprouty2 positively regulates T cell function and airway inflammation through regulation of CSK and LCK kinases.

PLoS biology (2021-03-09)
Anand Sripada, Kapil Sirohi, Lidia Michalec, Lei Guo, Jerome T McKay, Sangya Yadav, Mukesh Verma, James Good, Donald Rollins, Magdalena M Gorska, Rafeul Alam
ABSTRACT

The function of Sprouty2 (Spry2) in T cells is unknown. Using 2 different (inducible and T cell-targeted) knockout mouse strains, we found that Spry2 positively regulated extracellular signal-regulated kinase 1/2 (ERK1/2) signaling by modulating the activity of LCK. Spry2-/- CD4+ T cells were unable to activate LCK, proliferate, differentiate into T helper cells, or produce cytokines. Spry2 deficiency abrogated type 2 inflammation and airway hyperreactivity in a murine model of asthma. Spry2 expression was higher in blood and airway CD4+ T cells from patients with asthma, and Spry2 knockdown impaired human T cell proliferation and cytokine production. Spry2 deficiency up-regulated the lipid raft protein caveolin-1, enhanced its interaction with CSK, and increased CSK interaction with LCK, culminating in augmented inhibitory phosphorylation of LCK. Knockdown of CSK or dislodgment of caveolin-1-bound CSK restored ERK1/2 activation in Spry2-/- T cells, suggesting an essential role for Spry2 in LCK activation and T cell function.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
Tamoxifene, ≥99%
Sigma-Aldrich
Caveolin-1 Scaffolding Domain Peptide, Cell-permeable, Caveolin-1 scaffolding domain peptide (C1-SD82-101) fused at the N-terminus to the cell-permeable Antennapedia internalization sequence (43-58).